Evaluating ChatGPT's Diagnostic Capabilities: Insights, Limitations, and Future Directions
Emerging research evaluates ChatGPT's ability to assist in medical diagnosis, revealing high accuracy in identifying diseases and drugs but highlighting significant knowledge gaps and hallucination issues that need addressing.
Recent research investigations have explored the potential of ChatGPT, an advanced generative AI model, in medical diagnosis. As many individuals increasingly turn to AI for health-related inquiries, understanding the accuracy and reliability of these responses is crucial. A study published in the journal iScience by researchers led by Ahmed Abdeen Hamed from Binghamton University assessed ChatGPT's performance in identifying disease terms, drug names, genetic information, and symptoms.
The study involved testing ChatGPT with various biomedical queries. Remarkably, the AI achieved high accuracy rates: 88-97% for disease terms, 90-91% for drug names, and 88-98% for genetic information—outperforming initial expectations significantly. For example, ChatGPT correctly identified that cancer, hypertension, and fever are diseases, while Remdesivir is a drug, and BRCA is a gene linked to breast cancer. However, the AI's performance was less impressive in symptom identification, with accuracy ranging from 49-61%. The discrepancy may stem from the AI's training on informal language rather than standardized biomedical ontologies.
A notable issue uncovered was ChatGPT’s tendency to 'hallucinate' or generate fabricated genetic accession numbers, such as making up DNA sequence identifiers for genes like BRCA1. This highlights a critical challenge in relying solely on the AI for factual biomedical information.
The researchers utilized a machine learning tool called xFakeSci, which detects approximately 94% of false scientific papers, indicating that further integration of biomedical knowledge bases could mitigate hallucinations in large language models. Hamed emphasizes the importance of incorporating biomedical ontologies into these models to improve accuracy and reduce misinformation.
While the findings show promising capabilities, the study underscores that ChatGPT and similar models are not yet ready to replace professional medical advice. Nonetheless, ongoing improvements could lead to powerful tools that assist with initial diagnostics or information validation, provided their limitations are addressed.
Source: https://medicalxpress.com/news/2025-07-chatgpt-reveals-knowledge-gaps-hallucination.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Intersex Health Communication Guide Promotes Inclusivity and Respect in Canadian Healthcare
McGill University has released a pioneering guide to improve healthcare communication with intersex adults in Canada, promoting inclusivity, respect, and cultural competency to address existing barriers and discrimination.
Advances in Gastric and GE Junction Cancer Treatment: Durvalumab Combined with FLOT Shows Promising Results at ASCO
A groundbreaking phase 3 trial shows that combining durvalumab with FLOT chemotherapy significantly improves outcomes for patients with resectable gastric and GE junction cancer, offering new hope in cancer treatment.
Innovative Light Therapy Technology Boosts Healing and Pain Management in Dental Care
Groundbreaking light therapy device Nuralyte shows promise in accelerating healing and managing pain in dental procedures through targeted mitochondrial stimulation, with broader implications for tissue regeneration.
New Insights into How Smoking Influences Pancreatic Cancer Development
A groundbreaking study reveals how cigarette toxins promote pancreatic cancer through immune suppression and IL-22 production, opening new avenues for targeted therapies and personalized treatment strategies.